Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT01683955 · ClinicalTrials.gov registry record · Phase 1
Topical Tranexamic Acid and Acute Blood Loss in Total Hip Arthroplasty
A Phase 1 study, sponsored by Henry Ford Health System.
- Completed
- Registry status
- Phase 1
- Development phase
- 139
- Enrollment target
NCT01683955: Completed Phase 1 study, sponsored by Henry Ford Health System.
NCT01683955 is a Phase 1 study that has completed, run by Henry Ford Health System. The registered enrollment target is 139 participants, above the 60-participant average among 29,502 other Phase 1 trials with a reported enrollment target (132% higher). According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT01683955, a Phase 1 study, has completed, sponsored by Henry Ford Health System.
- COMPLETED
- Registry status
- Phase 1
- Development phase
- 139 participants
- Enrollment target
Study Summary
This study aims to assess postoperative blood loss and transfusion rates in total hip replacement after one-time administration of topical tranexamic acid.
Primary Outcome
Preoperative and lowest postoperative hemoglobin
Interventions
- DRUG Placebo
- DRUG Tranexamic acid
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 139 participants |
| Start Date | 2013-01-01 |
| Est. Completion | 2013-11-03 |
| Phase | Phase 1 |
What the finished NCT01683955 record still lists
NCT01683955 is an interventional study that assigns participants to a tested intervention. The registered 139 participants enrollment target is mid-sized for trials with a published cap, above the 60-participant average among 29,502 other Phase 1 trials with a reported enrollment target (132% higher).
The record links to 0 conditions, and to 2 interventions - of which Placebo is the first listed.
NCT01683955 does not publish any study locations in the registry export this page uses.
Frequently Asked Questions
What is clinical trial NCT01683955 about?
NCT01683955 is a clinical study titled "Topical Tranexamic Acid and Acute Blood Loss in Total Hip Arthroplasty". This study aims to assess postoperative blood loss and transfusion rates in total hip replacement after one-time administration of topical tranexamic acid.
What is the current status of trial NCT01683955?
This trial is currently completed. It is a Phase 1 study. The enrollment target is 139 participants. The study started on 2013-01-01. Estimated completion is 2013-11-03.
What interventions are being tested in trial NCT01683955?
The interventions under investigation include: Placebo (DRUG), Tranexamic acid (DRUG).
Who is sponsoring clinical trial NCT01683955?
This trial is sponsored by Henry Ford Health System, which has 234 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
How this trial's enrollment target compares
Where NCT01683955's enrollment target sits among peer trials
139 418th of 2000 higher than 1,583 of 2,000 other Phase 1 trials
participants (enrollment target), bucketed by value
Each bar is a band; taller bars hold more other Phase 1 trials. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count and share, and where it sits relative to this entry.
Source ClinicalTrials.gov registry export · 2026-08-08
Nationwide trials with similar profiles
Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.
Similar enrollment target
- NCT05645380 · 139 participants · Phase 2
Neoadjuvant TIL- and Response-Adapted Chemoimmunotherapy for TNBC
- NCT06239272 · 139 participants · Phase 1
NRSTS2021, A Risk Adapted Study Evaluating Maintenance Pazopanib, Limited Margin, Dose-Escalated Radiation Therapy and Selinexor in Non-Rhabdomyosarcoma Soft Tissue Sarcoma (NRSTS)
- NCT06252220 · 139 participants · Phase 1
First in Human Study in Subjects With Obesity, But Otherwise Healthy
- NCT06537128 · 139 participants · NA
Internet-delivered Cognitive-Behavioral Therapy for Adolescents With Autism and Anxiety
Similar registry start date
- NCT05962346 · started 2026-12 · NA
Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia
- NCT07125183 · started 2026-12 · Phase 2
Study on Efficacy and Tolerability of Weekly Doxorubicin in Elderly Patients With Advanced or Metastatic Leiomyosarcoma
- NCT07292298 · started 2026-11 · Phase 2
Phase 2 Single-Arm Rectal Cancer Brachytherapy for Patients With Low-Lying Residual Adenocarcinoma After Total Neoadjuvant Therapy to Improve Organ Preservation Rates
- NCT04263285 · started 2026-10 · NA
Treatment of Depression Post-SCI